Actuated Medical Awarded Phase I SBIR for Alcohol Addiction Treatment
BELLEFONTE, Pa. - Nov. 1, 2022 - PRLog -- Actuated Medical Inc. has been awarded a Phase I Small Business Innovative Research (SBIR) grant from the National Institutes of Health-National Institute on Alcohol Abuse and Alcoholism (NIH-NIAAA) entitled "Oscillated Insertion Tool for Minimally Invasive, Low-Damage, Accurate Placement of Delivery Cannula to Improve Efficacy for DREADDS Therapy in Alcohol Addiction Treatment".
Alcohol addiction is both a major public health burden and a complex neuroscience problem. Recently, the powerful research tools used to better understand neurological disorders like addiction have also gained interest as therapies. However, a crucial issue is that the medication used must be reliably and safely delivered to specific areas within the brain. The project will demonstrate feasibility of a vibrated tool to assist in the accurate placement of a very small delivery device that may ultimately improve alcohol addiction treatment.
"Actuated is focused on developing innovative medical devices to treat neurological diseases. The goal for this technology is to use our knowledge of vibrating needles to develop a medical device that reliably enables safer and more precise injections within the brain than is currently possible, paving the way for more effective treatments for conditions like alcohol addiction," said Maureen L. Mulvihill, Actuated Medical President, CEO, and Co-Founder.
About Actuated Medical, Inc.
Actuated Medical develops medical devices that integrate electronically controlled motion technologies that improve patient outcomes and reduce healthcare costs. Their development process focuses on intellectual property, regulatory, and reimbursement strategies to decrease commercialization risk and attract medical device technology acquisition partnerships. Their devices solve unmet clinical needs in target markets e.g., Neural Implant Insertion, GI, critical care, and pediatrics. Actuated Medical is a certified women-owned business located in Bellefonte, PA and is ISO 13485 certified.
More information about Actuated neural device innovations:
For more information about this topic, please contact Maureen L. Mulvihill, Ph.D. by phone at 814-355-0003 or email at firstname.lastname@example.org.
Additional information can be found by visiting: